Format

Send to

Choose Destination
Discov Med. 2016 Feb;21(114):135-42.

Immune evasion pathways and the design of dendritic cell-based cancer vaccines.

Author information

1
Department of Medicine Division of Medical Oncology, Duke University Medical Center, Durham, NC 27710, USA.

Abstract

Emerging data is suggesting that the process of dendritic cell (DC) tolerization is an important step in tumorigenesis. Our understanding of the networks within the tumor microenvironment that functionally tolerize DC function is evolving while methods for genetically manipulating DC populations in situ continue to develop. A more intimate understanding of the paracrine signaling pathways which mediate immune evasion by subverting DC function promises to provide novel strategies for improving the clinical efficacy of DC-based cancer vaccines. This will likely require a better understanding of both the antigen expression profile and the immune evasion network of the tumor and its associated stromal tissues.

PMID:
27011049
PMCID:
PMC4934601
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Discovery Medicine Icon for PubMed Central
Loading ...
Support Center